Lataa...
Rivastigmine in the treatment of patients with Alzheimer’s disease
Impairment of attention and memory in patients with Alzheimer’s disease (AD) is associated with significantly lower levels of acetylcholine. Inhibition of the breakdown of acetylcholine by blocking the enzymes acetylcholinesterase and butyrylcholinesterase with rivastigmine improves this cholinergic...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2654625/ https://ncbi.nlm.nih.gov/pubmed/19300554 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|